Long-term safety and efficacy of migalastat in adolescent patients with Fabry disease: Results from the ASPIRE study and open-label extension

被引:0
作者
Ramaswami, Uma [1 ]
Font-Montgomery, Esperanza E. [2 ,3 ]
Goker-Alpan, Ozlem [4 ]
Ortiz, Damara [5 ]
Sanchez-Valle, Amarilis [6 ]
Whitley, Chester B. [7 ]
Wilcox, William R. [8 ]
Jiang, Hai [9 ]
Lawson, Lee Ann [9 ]
Vosk, Jennie [9 ]
Yang, Haichen [9 ]
Hopkin, Robert J. [10 ]
机构
[1] Royal Free London NHS Fdn Trust, London, England
[2] Cent Michigan Univ, Mt Pleasant, MI USA
[3] Univ Pediatricians, Mt Pleasant, MI USA
[4] Lysosomal & Rare Disorders Res & Treatment Ctr, Fairfax, VA USA
[5] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[6] Univ S Florida, Tampa, FL USA
[7] Univ Minnesota, Minneapolis, MN USA
[8] Emory Univ, Atlanta, GA USA
[9] Amicus Therapeut Inc, Princeton, NJ USA
[10] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
关键词
D O I
10.1016/j.ymgme.2024.108910
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
283
引用
收藏
页数:2
相关论文
empty
未找到相关数据